Literature DB >> 3871582

Comparison of preoperative, operative and postoperative variables in asymptomatic or minimally symptomatic patients to severely symptomatic patients three years after coronary artery bypass grafting: analysis of 423 patients.

P J de Feyter, P W Serruys, R W Brower, M van den Brand, H J ten Katen, P G Hugenholtz, E Bos.   

Abstract

During a follow-up period of 3 years, among a consecutive series of 423 patients who gave informed consent for recatheterization both 1 and 3 years after coronary artery bypass grafting, the incidence of severely symptomatic patients with New York Heart Association class III or IV was 19% (79 of 423). The predictive value of approximately 80 clinical, angiographic and perioperative variables was too low to be of clinical value. Adverse clinical outcome was associated with a high closure rate of the grafts. Forty-six percent of the patients could not undergo reoperation because of unsuitable coronary anatomy. With intensive medical therapy half of these patients improved to functional class I or II, while of those patients who were reoperable 32% improved to class I or II with intensive pharmacologic treatment instead of reoperation. The nonresponders underwent reoperation, which resulted in improvement of symptoms to functional class I or II in most (83%).

Entities:  

Mesh:

Year:  1985        PMID: 3871582     DOI: 10.1016/0002-9149(85)90376-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery.

Authors:  J S Skinner; M Farrer; C J Albers; K Piper; H A Neil; P C Adams
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

Review 2.  Clinical assessment following coronary revascularization.

Authors:  K J Beatt; F Fath-Ordoubadi; T Huehns
Journal:  Int J Card Imaging       Date:  1993

3.  Early and long term results of re-operation for coronary artery disease.

Authors:  E S Akl; E Ozdogan; S K Ohri; M Barbir; J A Gaer; A G Mitchell; M H Yacoub
Journal:  Br Heart J       Date:  1992-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.